Suven Pharmaceuticals Ltd Share Holding Pattern

Home

Insights

Share Holding

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

18.4 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Promoters Holdings Over Time

Key Highlights

FIIs/FPIs increased their stake in the company by 0.26% from March 2024 to June 2024.
Mutual funds decreased their stake in the company by 0.49% from March 2024 to June 2024.

Latest Shareholding

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price of Suven Pharmaceuticals Ltd

Monitoring Suven Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

14 Jan 2025	1054.75	1059.95	1065.25	1050.1
13 Jan 2025	1049.95	1040.75	1057.65	1039.6
10 Jan 2025	1061.9	1101.05	1101.05	1057.1
09 Jan 2025	1103.55	1099	1129.7	1099
08 Jan 2025	1102.1	1100.95	1106.15	1086.45
07 Jan 2025	1092.8	1056.75	1118.55	1056.75
06 Jan 2025	1092.2	1106.75	1106.75	1080
03 Jan 2025	1105.75	1136.75	1136.75	1090.4
02 Jan 2025	1114.4	1096.7	1127.55	1089.4
01 Jan 2025	1123.95	1119.15	1136.05	1071

Date	Price (₹)
14 Jan 2025	1054.75
13 Jan 2025	1049.95
10 Jan 2025	1061.9
09 Jan 2025	1103.55
08 Jan 2025	1102.1
07 Jan 2025	1092.8
06 Jan 2025	1092.2
03 Jan 2025	1105.75
02 Jan 2025	1114.4
01 Jan 2025	1123.95

Suven Pharmaceuticals Ltd News Hub

Suven Pharmaceuticals schedules board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

28 Dec 2024 09:36

Suven Pharmaceuticals acquires 56% stake in NJ Bio Inc.

Suven Pharmaceuticals has acquired 56% equity share capital of NJ Bio, Inc. (target compan...

23 Dec 2024 11:34

Suven Pharmaceuticals strengths its ADC offering with acquisition of NJ Bio

Suven Pharmaceuticals announced the acquisition of a controlling stake in NJ Bio Inc. (NJ ...

07 Dec 2024 11:24

Suven Pharmaceuticals to acquire majority stake in US based NJ Bio

Suven Pharmaceuticals has executed definitive agreements today, i.e. 07 December 2024, for...

07 Dec 2024 11:20

Suven Pharma to acquire majority stake in US-based NJ Bio

The $64.4 million deal includes both primary equity infusion and secondary acquisition. As...

07 Dec 2024 17:20

Suven Pharmaceuticals Ltd Surges 4.23%

Suven Pharmaceuticals Ltd gained 4.23% today to trade at Rs 1359. The BSE Healthcare index...

02 Dec 2024 09:30

Document

Annual Reports

Annual Report 2024

Credit Ratings

Credit Report 2024

Concalls

June 2024

Mar 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Dec 2022

Nov 2022

Aug 2022

June 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

June 2021

Feb 2021

June 2024

Mar 2024

Feb 2024

Nov 2023

Aug 2023

June 2023

Feb 2023

Dec 2022

Nov 2022

Aug 2022

June 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

June 2021

Feb 2021

Popular Search

Suven Pharmaceuticals Ltd pe ratio

Suven Pharmaceuticals Ltd eps

Suven Pharmaceuticals Ltd share price history

Suven Pharmaceuticals Ltd dividend

Suven Pharmaceuticals Ltd market cap

Suven Pharmaceuticals Ltd pb ratio

Sun Pharmaceuticals Industries Ltd share holding pattern

Divis Laboratories Ltd share holding pattern

Cipla Ltd share holding pattern

Dr Reddys Laboratories Ltd share holding pattern

Mankind Pharma Ltd share holding pattern

Torrent Pharmaceuticals Ltd share holding pattern

Zydus Lifesciences Ltd share holding pattern

Lupin Ltd share holding pattern

Aurobindo Pharma Ltd share holding pattern

Alkem Laboratories Ltd share holding pattern

Abbott India Ltd share holding pattern

FAQs for Share Holding Pattern of Suven Pharmaceuticals Ltd

On what factors does the shareholding pattern of Suven Pharmaceuticals Ltd change frequently?

The shareholding pattern of Suven Pharmaceuticals Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Suven Pharmaceuticals Ltd's shareholding pattern updated?

The Suven Pharmaceuticals Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Suven Pharmaceuticals Ltd?

Categories included in the shareholding pattern of Suven Pharmaceuticals Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Suven Pharmaceuticals Ltd important for investors?

The shareholding pattern of Suven Pharmaceuticals Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Suven Pharmaceuticals Ltd?

The latest shareholding pattern of Suven Pharmaceuticals Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.